AbbVie Inc. vs United Parcel Service, Inc.: Strategic Comparison
Key Differences at a Glance
| Field | AbbVie Inc. | United Parcel Service, Inc. |
|---|---|---|
| Revenue | $61.2B | $88.7B |
| Founded | 2013 | 1907 |
| Employees | 57,000 | 460,000 |
| Market Cap | $451.5B | $98.9B |
| Headquarters | United States | United States |
Quick Stats Comparison
| Metric | AbbVie Inc. | United Parcel Service, Inc. |
|---|---|---|
| Revenue | $61.2B | $88.7B |
| Founded | 2013 | 1907 |
| Headquarters | North Chicago, Illinois | Atlanta, Georgia |
| Market Cap | $451.5B | $98.9B |
| Employees | 57,000 | 460,000 |
AbbVie Inc. Revenue vs United Parcel Service, Inc. Revenue — Year by Year
| Year | AbbVie Inc. | United Parcel Service, Inc. | Leader |
|---|---|---|---|
| 2025 | $61.2B | $88.7B | United Parcel Service, Inc. |
| 2024 | $56.3B | $91.1B | United Parcel Service, Inc. |
| 2023 | $54.3B | $91.0B | United Parcel Service, Inc. |
| 2022 | $58.1B | N/A | AbbVie Inc. |
| 2021 | $56.2B | N/A | AbbVie Inc. |
Business Model Breakdown
Overview: AbbVie Inc. vs United Parcel Service, Inc.
This in-depth comparison examines AbbVie Inc. and United Parcel Service, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching AbbVie Inc. on its own, evaluating United Parcel Service, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between AbbVie Inc. and United Parcel Service, Inc. is widest.
On the headline numbers, AbbVie Inc. reports annual revenue of $61.2B against $88.7B for United Parcel Service, Inc., while their respective market capitalizations stand at $451.5B and $98.9B. AbbVie Inc. is headquartered in United States and United Parcel Service, Inc. operates from United States, and those different home markets shape how each company competes.
AbbVie Inc.: AbbVie began as the separated pharmaceutical arm of Abbott Laboratories and became one of the world's largest biopharma companies by using Humira cash flow to build a broader portfolio. The company now presents itself as a diversified specialty-medicine platform rather than a single-product story.
United Parcel Service, Inc.: UPS is not simply a delivery company. It is a daily density network: the more packages moving through routes, hubs, aircraft, and delivery stops, the more efficiently each incremental package can be handled.
Business Models: How AbbVie Inc. and United Parcel Service, Inc. Make Money
AbbVie Inc. and United Parcel Service, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between AbbVie Inc. and United Parcel Service, Inc..
AbbVie Inc. business model: AbbVie earns revenue from patented and specialty medicines sold globally through healthcare systems, insurers, distributors, specialists, hospitals, and aesthetics providers. Immunology is the largest segment, supported by neuroscience, oncology, aesthetics, eye care, and other therapeutics.
United Parcel Service, Inc. business model: UPS makes money from U.S. domestic package delivery, international package delivery, air and ground shipping, brokerage, contract logistics, healthcare cold chain, freight forwarding, returns, insurance, UPS Store services, and digital logistics offerings.
Competitive Advantage: AbbVie Inc. vs United Parcel Service, Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of AbbVie Inc. stack up against those of United Parcel Service, Inc..
AbbVie Inc. competitive advantage: AbbVie's advantage comes from deep immunology scale, specialist sales relationships, strong cash flow, global clinical and regulatory capabilities, and a portfolio led by Skyrizi, Rinvoq, Botox, Vraylar, Imbruvica, Venclexta, and Elahere.
United Parcel Service, Inc. competitive advantage: UPS's advantage is route density, integrated air-ground operations, trusted service quality, global customs and brokerage capability, package tracking data, enterprise customer relationships, and specialized healthcare logistics infrastructure.
Growth Strategy: Where AbbVie Inc. and United Parcel Service, Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how AbbVie Inc. and United Parcel Service, Inc. each plan to expand from here.
AbbVie Inc. growth strategy: AbbVie's growth strategy is to expand indications for Skyrizi and Rinvoq, defend Botox and aesthetics, invest in neuroscience and oncology, use targeted acquisitions to add late-stage assets, and maintain disciplined cash generation after Humira's decline.
United Parcel Service, Inc. growth strategy: UPS is emphasizing higher-yield parcels, SMB penetration, healthcare logistics, international package growth, automation, RFID-enabled package visibility, network reconfiguration, and disciplined capital spending.
Financial Picture: AbbVie Inc. vs United Parcel Service, Inc.
A closer look at the financial trajectory of AbbVie Inc. and United Parcel Service, Inc. rounds out the comparison.
AbbVie Inc.: AbbVie generated $61.160 billion in FY2025 net revenue, up 8.6% on a reported basis, with immunology contributing $30.406 billion. Q1 2026 revenue reached $15.002 billion, showing continued growth after the Humira patent cliff as Skyrizi and Rinvoq scaled.
United Parcel Service, Inc.: UPS reported USD 88.7 billion in 2025 revenue, USD 7.9 billion in operating profit, and 8.9% operating margin. The company delivered 5.2 billion packages and continued shifting toward higher-yielding volume, healthcare logistics, SMBs, B2B, and international opportunities.
Company-Specific SWOT Notes
AbbVie Inc.
Skyrizi generated $17.
AbbVie is no longer only an immunology company.
Humira's decline shows the core weakness of the pharmaceutical model: even extraordinary blockbusters eventually lose exclusivity.
Even after diversification, AbbVie's earnings power is tied heavily to Skyrizi, Rinvoq, Botox, Vraylar, Imbruvica, Venclexta, and Humira.
Cerevel adds neuroscience pipeline depth, while ImmunoGen adds Elahere and antibody-drug conjugate expertise.
Rinvoq belongs to the JAK inhibitor class, which carries FDA boxed-warning scrutiny, while Humira faces biosimilars and other franchises face competitors from Johnson & Johnson, Eli Lilly, Pfizer, Merck, Amgen, Roche, Novartis, Sanofi, and AstraZeneca.
United Parcel Service, Inc.
UPS's advantage is route density, integrated air-ground operations, trusted service quality, global customs and brokerage capability, package tracking data, enterprise customer relationships, and specialized healthcare logistics infrastructure.
UPS wins when package density, reliable service, and integrated air-ground logistics make it cheaper and safer for customers to use UPS than to stitch together alternatives.
The biggest risk is that falling low-yield volume, labor inflation, or Amazon-related shifts reduce network density faster than UPS can reprice and reconfigure operations.
UPS is emphasizing higher-yield parcels, SMB penetration, healthcare logistics, international package growth, automation, RFID-enabled package visibility, network reconfiguration, and disciplined capital spending.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | United Parcel Service, Inc. | United Parcel Service, Inc. reports the larger revenue base ($88.7B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | United Parcel Service, Inc. | Founded in 2013 vs 1907. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Tied | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | United Parcel Service, Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | AbbVie Inc. | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
United Parcel Service, Inc. reports the larger revenue base ($88.7B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 2013 vs 1907. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: AbbVie Inc. or United Parcel Service, Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: AbbVie Inc. vs United Parcel Service, Inc.
Is AbbVie Inc. better than United Parcel Service, Inc.?
Verdict: Between AbbVie Inc. and United Parcel Service, Inc., United Parcel Service, Inc. is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, United Parcel Service, Inc. comes out ahead in this AbbVie Inc. vs United Parcel Service, Inc. comparison.
Who earns more — AbbVie Inc. or United Parcel Service, Inc.?
United Parcel Service, Inc. earns more with $88.7B in annual revenue versus AbbVie Inc.'s $61.2B. United Parcel Service, Inc. leads on total revenue based on latest verified figures.
Which company has higher revenue — AbbVie Inc. or United Parcel Service, Inc.?
AbbVie Inc. reported $61.2B, while United Parcel Service, Inc. reported $88.7B. The revenue leader is United Parcel Service, Inc. based on latest verified figures.
AbbVie Inc. revenue vs United Parcel Service, Inc. revenue — which is higher?
AbbVie Inc. revenue: $61.2B. United Parcel Service, Inc. revenue: $61.2B. United Parcel Service, Inc. has the larger revenue base of the two companies.
Sources & References
- SEC EDGAR: AbbVie Inc. Annual Filings (10-K, 8-K)
- AbbVie Inc. Corporate Website
- AbbVie Inc. Annual Report 2025 - Revenue and Financial Data
- news.abbvie.com
- prnewswire.com
- abbvie.com
- news.abbvie.com
- investors.abbvie.com
- news.abbvie.com
- news.abbvie.com
- news.abbvie.com
- investors.abbvie.com
- cms.gov
- fda.gov
- SEC EDGAR: United Parcel Service, Inc. Annual Filings (10-K, 8-K)
- United Parcel Service, Inc. Corporate Website
- United Parcel Service, Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- investors.ups.com
- about.ups.com